Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03942653 |
| Title | Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Big Ten Cancer Research Consortium |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University Feinberg School of Medicine | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| University of Illinois Cancer Center | RECRUITING | Chicago | Illinois | 60612 | United States | Details |
| University of Iowa Hospitals and Clinics | RECRUITING | Iowa City | Iowa | 52242 | United States | Details |
| Univeristy of Maryland | RECRUITING | Baltimore | Maryland | 21201 | United States | Details |
| University of Michigan Health System | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| University of Minnesota: Masonic Cancer Center | RECRUITING | Minneapolis | Minnesota | 55455 | United States | Details |
| University of Wisconsin | RECRUITING | Madison | Wisconsin | 53705 | United States | Details |